Skip to main content

Table 2 Correlation between PAI-1 and the anthropometric measures and blood pressure measurements and the laboratory data in obese group

From: Assessment of plasminogen activator inhibitor-1 in obese Egyptian children

PAI-1 in obese group

R

p

Height (cm)

0.2

0.3

Height (SDS)

0.1

0.4

Weight (kg)

0.6

0.000**

Weight (SDS)

0.2

0.3

BMI (kg/m2)

0.6

0.000**

BMI (SDS)

0.4

0.01*

Waist circumference (cm)

0.09

0.6

Hip circumference (cm)

0.1

0.4

W/H ratio

0.7

0.000**

Biceps skin fold (mm)

0.4

0.03*

Triceps skin fold (mm)

0.3

0.04*

Subscapular skin fold (mm)

0.3

0.04*

Systolic Bp (mmHg)

0.7

0.000**

Diastolic Bp (mmHg)

0.3

0.04*

Cholesterol (mg/dl)

0.5

0.000**

Triglycerides (mg/dl)

0.4

0.02*

HDL-c (mg/dl)

0.3

0.08

LDL-c (mg/dl)

0.6

0.000**

FBS (mg/dl)

0.1

0.4

Insulin (μIU/ml)

0.5

0.000**

HOMA-IR

0.5

0.02*

  1. Correlations between variables were done using Pearson’s correlation coefficients for the parametric data and Spearman correlation coefficients for nonparametric data
  2. *p value statistically significant < 0.05
  3. **p value highly significant < 0.01